TECX - Tectonic Therapeutic, Inc.
NEXT EARNINGS:
Mar 19, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$60.00
DETAILS
HIGH:
$60.00
LOW:
$60.00
MEDIAN:
$60.00
CONSENSUS:
$60.00
UPSIDE:
185.04%
Market Cap:
393.98M
Volume:
3,477,598
Avg Volume:
312,118
52 Week Range:
13.7-36.11
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.59
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
51
IPO Date:
N/A
EPS (TTM):
-3.93
P/E Ratio:
-11.76
Revenue (TTM):
N/A
Total Assets:
152.91M
Total Debt:
3.30M
Cash & Equiv:
141.24M
Rev Growth (5Y):
N/A
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-41.0%
Debt/Equity:
0.02
Track Record
Statements >| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | (57.98M) | (42.82M) | (32.18M) | (8.93M) | (119.71M) | (72.97M) | (46.36M) | (18.65M) | (4.66M) |
| EPS | -3.93 | -11.59 | -29.05 | -33.36 | -39.68 | -31.92 | -23.41 | -9.35 | -2.34 |
| Total Assets | 152.91M | 39.40M | 47.21M | 32.88M | 271.23M | 200.51M | 133.48M | 7.02M | 5.40M |
| Total Debt | 3.30M | 4.34M | 5.79M | 1.05M | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | 141.24M | 28.77M | 35.97M | 28.06M | 259.68M | 187.04M | 126.30M | 5.96M | 5.36M |
| Operating Cash Flow | (59.08M) | (40.68M) | (97.21M) | (12.45M) | (98.80M) | (67.67M) | (37.65M) | (16.38M) | (3.31M) |
| Free Cash Flow | (59.24M) | (40.96M) | (97.47M) | (14.58M) | (99.98M) | (69.25M) | (39.48M) | (16.77M) | (3.31M) |
| FCF per Share | -4.01 | -11.09 | -26.74 | -4.08 | -33.14 | -30.29 | -19.93 | -8.40 | -1.66 |
| Book Value | 140.78M | (84.64M) | (45.65M) | (14.96M) | 254.34M | 186.01M | 122.18M | 3.37M | 4.42M |
| Cash & ST Investments | 141.24M | 28.77M | 35.97M | 28.06M | 259.68M | 187.04M | 126.30M | 5.96M | 5.36M |
| ROC Equity | -0.41 | N/A | N/A | N/A | -0.47 | -0.39 | -0.38 | -5.54 | -1.05 |